Penehyclidine for PONV Prophylaxis After Strabismus Surgery
- Registration Number
- NCT04054479
- Brief Summary
Patients scheduled for elective strabismus surgery under general anesthesia in the First Affiliated Hospital of Nanjing Medical University will be included in this study.
Patients 1)ASA I or II, 2)aged 3-65 years, 3)scheduled for elective strabismus surgery under general anesthesia, will be included in the study. Patients 1)had prior PONV, 2)severe motion sickness, 3)a history of ophthalmic surgery, 4)had received drugs known to have antiemetic effects, will be excluded from the study.
The primary aim is to evaluate the prophylaxis effect of penehyclidine(a novel long acting selective anticholinergic agent developed in China) on postoperative nausea and vomiting after strabismus surgery. Secondary outcomes include the effect of PONV risk factors and surgical technique on PONV rank score, occurance of oculocardiac reflex, time to extubation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 228
- ASA I or II
- Aged 3-65 years
- Scheduled for elective strabismus surgery under general anesthesia
- Had prior PONV
- Severe motion sickness
- A history of ophthalmic surgery
- Had received drugs known to have antiemetic effects in 24h before surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Normal Saline normal saline Patients in this arm will receive normal saline after anesthesia intubation. Penehyclidine Penehyclidine Patients in this arm will receive penehyclidine after anesthesia intubation.
- Primary Outcome Measures
Name Time Method Incidence of PONV From extubation to 48 hours after surgery Occurance of postoperative nausea and vomiting after strabismus surgery
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The First Affiliated Hospital of Nanjing Medical University
🇨🇳Nanjing, Jiangsu, China